Chronological improvement in precision oncology implementation in Japan

In Japan, comprehensive genomic profiling (CGP) tests for refractory cancer patients have been approved since June 2019, under the requirement that all cases undergoing CGP tests are annotated by the molecular tumor board (MTB) at each government‐designated hospital. To investigate improvement in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunami, Kuniko, Naito, Yoichi, Komine, Keigo, Amano, Toraji, Ennishi, Daisuke, Imai, Mitsuho, Kage, Hidenori, Kanai, Masashi, Kenmotsu, Hirotsugu, Koyama, Takafumi, Maeda, Takahiro, Morita, Sachi, Sakai, Daisuke, Kohsaka, Shinji, Tsuchihara, Katsuya, Saigusa, Yusuke, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633287/
https://www.ncbi.nlm.nih.gov/pubmed/35976133
http://dx.doi.org/10.1111/cas.15517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633287/
https://www.ncbi.nlm.nih.gov/pubmed/35976133
http://dx.doi.org/10.1111/cas.15517

Ejemplares similares